The beneficial intention-to-treat survival effect of living donation in patients with hepatocellular cancer waiting for liver transplantation

被引：0

作者：

Lai, Q. ^{[1
,2
]}

Sapisochin, G. ^{[3
]}

Gorgen, A. ^{[3
]}

Vitale, A. ^{[4
]}

Halazun, K. ^{[5
]}

Iesari, S. ^{[2
]}

Viveiros, A. ^{[6
]}

Bhangui, P. ^{[7
]}

Mennini, G. ^{[1
]}

Wong, T. ^{[8
]}

Uemoto, S. ^{[9
]}

Lin, C. -C. ^{[10
]}

Mittler, J. ^{[11
]}

Ikegami, T. ^{[12
]}

Xie, Q. -F. ^{[13
]}

Zheng, S. -S. ^{[13
]}

Soejima, Y. ^{[12
]}

Hoppe-Lotichius, M. ^{[11
]}

Chen, C. -L. ^{[10
]}

Kaido, T. ^{[9
]}

Lo, C. M. ^{[8
]}

Rossi, M. ^{[1
]}

Soin, A. S. ^{[7
]}

Finkenstedt, A. ^{[6
]}

Emond, J. C. ^{[5
]}

Cillo, U.

Lerut, J. ^{[2
]}

机构：

[1] Sapienza Univ, Rome, Italy

[2] UCL, Brussels, Belgium

[3] Univ Toronto, Toronto, ON, Canada

[4] Univ Padua, Padua, Italy

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] Univ Innsbruck, Innsbruck, Austria

[7] Medanta Medicity Hosp, Sect 38, Innsbruck, Austria

[8] Univ Hong Kong, Hong Kong, Peoples R China

[9] Kyoto Univ, Kyoto, Japan

[10] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[11] Mainz Univ, Mainz, Germany

[12] Kyushu Univ, Fukuoka, Japan

[13] Shulan Hlth Zhejiang Univ Hosp, Hangzhou, Zhejiang, Peoples R China

来源：

TRANSPLANTATION | 2021年 / 105卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O-005

引用

页码：5 / 6

页数：2

共 50 条

[1] THE BENEFICIAL INTENTION-TO-TREAT SURVIVAL EFFECT OF LIVING DONATION IN PATIENTS WITH HEPATOCELLULAR CANCER WAITING FOR LIVER TRANSPLANT
Lai, Quirino
Sapisochin, Gonzalo
Gorgen, Andre
Halazun, Karim
Schaefer, Benedikt
Bhangui, Prashant
Mennini, Gianluca
Wong, Tiffany
Uemoto, Shinji
Lin, Chih-Che
Mittler, Jens
Ikegami, Toru
Zheng, Shu-Sen
Cillo, Umberto
Lerut, Jan
TRANSPLANT INTERNATIONAL, 2021, 34 : 14 - 14
[2] INTENTION-TO-TREAT SURVIVAL BENEFIT SELECTS PATIENTS WITH HEPATOCELLULAR CANCER WAITING FOR LIVER TRANSPLANTATION
Lai, Quirino
Vitale, Alessandro
Iesari, Samuele
Finkenstedt, Armin
Melandro, Fabio
Spoletini, Gabriele
Hoppe-Lotichius, Maria
Sandri, Giovanni B. Levi
Manzia, Tommaso M.
Nicolini, Daniele
Avolio, Alfonso W.
Cillo, Umberto
Graziadei, Ivo
Rossi, Massimo
Tsochatzis, Emmanouil
Otto, Gerd
Ettorre, Giuseppe M.
Tisone, Giuseppe
Vivarelli, Marco
Agnes, Salvatore
Lerut, Jan
TRANSPLANT INTERNATIONAL, 2017, 30 : 92 - 92
[3] Intention-to-Treat Survival Benefit of Liver Transplantation in Patients with Hepatocellular Cancer
Lai, Q.
Vitale, A.
Iesari, S.
Finkenstedt, A.
Mennini, G.
Spoletini, G.
Hoppe-Lotichius, M.
Vennarecci, G.
Manzia, T. M.
Nicolini, D.
Avolio, A. W.
Cillo, U.
Graziadei, I.
Rossi, M.
Tsochatzis, E.
Otto, G.
Ettorre, G. M.
Tisone, G.
Vivarelli, M.
Agnes, S.
Lerut, J.
TRANSPLANTATION, 2017, 101 (05) : 33 - 34
[4] Intention-to-Treat Survival Benefit of Liver Transplantation in Patients With Hepatocellular Cancer
Lai, Quirino
Vitale, Alessandro
Iesari, Samuele
Finkenstedt, Armin
Mennini, Gianluca
Spoletini, Gabriele
Hoppe-Lotichius, Maria
Vennarecci, Giovanni
Manzia, Tommaso M.
Nicolini, Daniele
Avolio, Alfonso W.
Frigo, Anna Chiara
Graziadei, Ivo
Rossi, Massimo
Tsochatzis, Emmanouil
Otto, Gerd
Ettorre, Giuseppe M.
Tisone, Giuseppe
Vivarelli, Marco
Agnes, Salvatore
Cillo, Umberto
Lerut, Jan
HEPATOLOGY, 2017, 66 (06) : 1910 - 1919
[5] WAITING TIME IMPACTS ON INTENTION-TO-TREAT SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CANCER WAITING FOR LIVER TRANSPLANTATION: A MULTICENTRE EUROPEAN STUDY GROUP
Lai, Quirino
Otto, Gerd
Graziadei, Ivo
Rossi, Massimo
Tisone, Giuseppe
Avolio, Alfonso W.
Goffette, Pierre
Pitton, Michael B.
Vogel, Wolfgang
Lerut, Jan
TRANSPLANT INTERNATIONAL, 2015, 28 : 56 - 56
[6] An intention-to-treat competing-risk model for candidates with hepatocellular cancer waiting for liver transplantation
Lai, Q.
Cucchetti, A.
Vitale, A.
Halazun, K.
Iesari, S.
Lehner, K.
Bhangui, P.
Mennini, G.
Wong, T.
Kaido, T.
Lin, C. C.
Hoppe-Lotichius, M.
Ikegami, T.
Xie, Q. F.
Zhe, Y.
Zheng, S. S.
Soejima, Y.
Otto, G.
Chen, C. L.
Uemoto, S.
Lo, C. M.
Rossi, M.
Soin, A. S.
Finkenstedt, A.
Emond, J. C.
Cillo, U.
Lerut, J.
DIGESTIVE AND LIVER DISEASE, 2019, 51 : E13 - E13
[7] An intention-to-treat competing-risk model for candidates with hepatocellular cancer waiting for liver transplantation
Lai, Q.
Cucchetti, A.
Halazun, K.
Cillo, U.
Iesari, S.
Finkenstedt, A.
Soin, A. S.
Rossi, M.
Uemoto, S.
Chen, C. -L
Hoppe-Lotichius, M.
Soejima, Y.
Xie, Q. -F
Zheng, S. -S
Lo, C. M.
Lerut, J.
TRANSPLANTATION, 2019, 103 (08) : 57 - 58
[8] Evaluation of the Intention-to-Treat Benefit of Living Donation in Patients With Hepatocellular Carcinoma Awaiting a Liver Transplant
Lai, Quirino
Sapisochin, Gonzalo
Gorgen, Andre
Vitale, Alessandro
Halazun, Karim J.
Iesari, Samuele
Schaefer, Benedikt
Bhangui, Prashant
Mennini, Gianluca
Wong, Tiffany C. L.
Uemoto, Shinji
Lin, Chih-Che
Mittler, Jens
Ikegami, Toru
Yang, Zhe
Frigo, Anna Chiara
Zheng, Shu-Sen
Soejima, Yuji
Hoppe-Lotichius, Maria
Chen, Chao-Long
Kaido, Toshimi
Lo, Chung Mau
Rossi, Massimo
Soin, Arvinder Singh
Finkenstedt, Armin
Emond, Jean C.
Cillo, Umberto
Lerut, Jan Paul
JAMA SURGERY, 2021, 156 (09)
[9] Beneficial impact of living donor liver transplantation on the mortality on the waiting list and the global results of transplantation: An intention-to-treat analysis.
Durand, F
Belghiti, J
Sommacale, D
Sauvanet, A
Bernuau, J
Farges, O
Valla, D
HEPATOLOGY, 2001, 34 (04) : 651A - 651A
[10] Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list
Yao, FY
Bass, NM
Nikolai, B
Davern, TJ
Kerlan, R
Wu, V
Ascher, NL
Roberts, JP
LIVER TRANSPLANTATION, 2002, 8 (10) : 873 - 883

← 1 2 3 4 5 →